BioSpace News Archive

Matinas BioPharma Holdings, Inc. has been invited to present a Company overview at the Piper Sandler 33rd Annual Virtual Healthcare Conference, being held November 29 – December 2, 2021.

Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced data published in the New England Journal of Medicine (NEJM) evaluating the safety and efficacy of OTL-203 for the treatment of the Hurler subtype of Mucopolysaccharidosis type I (MPS-IH).

Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, announced today that the data from the Phase 3 PROPEL pivotal trial, assessing the efficacy, safety and tolerability of AT-GAA in adults with late-onset Pompe disease compared to the standard of care, alglucosidase alfa, were published online in The Lancet Neurology.

CareDx, Inc. (Nasdaq: CDNA) – today announced the enrollment of the first patients in what will be the largest ever digital study measuring the impact of AlloCare™, a tech-enabled mobile health app, on organ transplant patient outcomes.

New data from the AZD7442 COVID-19 PROVENT prevention and TACKLE outpatient treatment Phase III trials both showed robust efficacy from a one-time intramuscular (IM) dose of the long-acting antibody (LAAB) combination.

NuVasive, Inc. (NASDAQ: NUVA), announced today that NuVasive CEO J. Christopher Barry will virtually present at the Piper Sandler 33rd Annual Virtual Healthcare Conference.

Cardiff Oncology, Inc., a clinical-stage oncology company developing new precision medicine treatment options for cancer patients in indications with the greatest unmet medical need, announced that Pfizer Inc. has made a $15 million equity investment in the company as part of the Pfizer Breakthrough Growth Initiative, a program focused on funding innovative science to meet patient needs.

Omega Therapeutics, Inc. today announced that Mahesh Karande , President and Chief Executive Officer, Roger Sawhney, M.D., Chief Financial Officer, and Thomas McCauley, Ph.D., Chief Scientific Officer, will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference taking place from November 29 – December 2, 2021.

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), today reports its financial results for the quarter ended September 30, 2021 and provides a corporate update.

ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), today provided a corporate update and reported financial results for the fiscal year ended September 30, 2021.